138 related articles for article (PubMed ID: 30910586)
1. Proton pump inhibitor pantoprazole inhibits gastric cancer metastasis via suppression of telomerase reverse transcriptase gene expression.
Zhang B; Ling T; Zhaxi P; Cao Y; Qian L; Zhao D; Kang W; Zhang W; Wang L; Xu G; Zou X
Cancer Lett; 2019 Jun; 452():23-30. PubMed ID: 30910586
[TBL] [Abstract][Full Text] [Related]
2. Proton pump inhibitor pantoprazole inhibits the proliferation, self‑renewal and chemoresistance of gastric cancer stem cells via the EMT/β‑catenin pathways.
Feng S; Zheng Z; Feng L; Yang L; Chen Z; Lin Y; Gao Y; Chen Y
Oncol Rep; 2016 Dec; 36(6):3207-3214. PubMed ID: 27748935
[TBL] [Abstract][Full Text] [Related]
3. Proton pump inhibitor pantoprazole abrogates adriamycin-resistant gastric cancer cell invasiveness via suppression of Akt/GSK-β/β-catenin signaling and epithelial-mesenchymal transition.
Zhang B; Yang Y; Shi X; Liao W; Chen M; Cheng AS; Yan H; Fang C; Zhang S; Xu G; Shen S; Huang S; Chen G; Lv Y; Ling T; Zhang X; Wang L; Zhuge Y; Zou X
Cancer Lett; 2015 Jan; 356(2 Pt B):704-12. PubMed ID: 25449432
[TBL] [Abstract][Full Text] [Related]
4. Proton pump inhibitor selectively suppresses proliferation and restores the chemosensitivity of gastric cancer cells by inhibiting STAT3 signaling pathway.
Huang S; Chen M; Ding X; Zhang X; Zou X
Int Immunopharmacol; 2013 Nov; 17(3):585-92. PubMed ID: 23973653
[TBL] [Abstract][Full Text] [Related]
5. C-Type Lectin-Like Receptor 2 Suppresses AKT Signaling and Invasive Activities of Gastric Cancer Cells by Blocking Expression of Phosphoinositide 3-Kinase Subunits.
Wang L; Yin J; Wang X; Shao M; Duan F; Wu W; Peng P; Jin J; Tang Y; Ruan Y; Sun Y; Gu J
Gastroenterology; 2016 May; 150(5):1183-1195.e16. PubMed ID: 26855187
[TBL] [Abstract][Full Text] [Related]
6. Kras mutations increase telomerase activity and targeting telomerase is a promising therapeutic strategy for Kras-mutant NSCLC.
Liu W; Yin Y; Wang J; Shi B; Zhang L; Qian D; Li C; Zhang H; Wang S; Zhu J; Gao L; Zhang Q; Jia B; Hao L; Wang C; Zhang B
Oncotarget; 2017 Jan; 8(1):179-190. PubMed ID: 27329725
[TBL] [Abstract][Full Text] [Related]
7. Effect of pantoprazole on human gastric adenocarcinoma SGC7901 cells through regulation of phospho‑LRP6 expression in Wnt/β-catenin signaling.
Shen W; Zou X; Chen M; Shen Y; Huang S; Guo H; Zhang L; Liu P
Oncol Rep; 2013 Aug; 30(2):851-5. PubMed ID: 23754096
[TBL] [Abstract][Full Text] [Related]
8. EphA2 promotes epithelial-mesenchymal transition through the Wnt/β-catenin pathway in gastric cancer cells.
Huang J; Xiao D; Li G; Ma J; Chen P; Yuan W; Hou F; Ge J; Zhong M; Tang Y; Xia X; Chen Z
Oncogene; 2014 May; 33(21):2737-47. PubMed ID: 23752181
[TBL] [Abstract][Full Text] [Related]
9. Bortezomib-mediated down-regulation of telomerase and disruption of telomere homeostasis contributes to apoptosis of malignant cells.
Ci X; Li B; Ma X; Kong F; Zheng C; Björkholm M; Jia J; Xu D
Oncotarget; 2015 Nov; 6(35):38079-92. PubMed ID: 26472030
[TBL] [Abstract][Full Text] [Related]
10. Pantoprazole Induces Mitochondrial Apoptosis and Attenuates NF-κB Signaling in Glioma Cells.
Geeviman K; Babu D; Prakash Babu P
Cell Mol Neurobiol; 2018 Nov; 38(8):1491-1504. PubMed ID: 30302629
[TBL] [Abstract][Full Text] [Related]
11. Telomerase reverse transcriptase promotes epithelial-mesenchymal transition and stem cell-like traits in cancer cells.
Liu Z; Li Q; Li K; Chen L; Li W; Hou M; Liu T; Yang J; Lindvall C; Björkholm M; Jia J; Xu D
Oncogene; 2013 Sep; 32(36):4203-13. PubMed ID: 23045275
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic Targeting of
Huang M; Zeki J; Sumarsono N; Coles GL; Taylor JS; Danzer E; Bruzoni M; Hazard FK; Lacayo NJ; Sakamoto KM; Dunn JCY; Spunt SL; Chiu B
Cancer Res; 2020 Mar; 80(5):1024-1035. PubMed ID: 31900258
[TBL] [Abstract][Full Text] [Related]
13. Constitutive expression of PPARγ inhibits proliferation and migration of gastric cancer cells and down-regulates Wnt/β-Catenin signaling pathway downstream target genes TERT and ENAH.
Guo F; Ren X; Dong Y; Hu X; Xu D; Zhou H; Meng F; Tian W; Zhao Y
Gene; 2016 Jun; 584(1):31-37. PubMed ID: 26956036
[TBL] [Abstract][Full Text] [Related]
14. Feedback regulation of telomerase reverse transcriptase: new insight into the evolving field of telomerase in cancer.
Wu XQ; Huang C; He X; Tian YY; Zhou DX; He Y; Liu XH; Li J
Cell Signal; 2013 Dec; 25(12):2462-8. PubMed ID: 23993966
[TBL] [Abstract][Full Text] [Related]
15. Selective induction of apoptosis with proton pump inhibitor in gastric cancer cells.
Yeo M; Kim DK; Kim YB; Oh TY; Lee JE; Cho SW; Kim HC; Hahm KB
Clin Cancer Res; 2004 Dec; 10(24):8687-96. PubMed ID: 15623654
[TBL] [Abstract][Full Text] [Related]
16. miR-302b inhibits tumorigenesis by targeting EphA2 via Wnt/ β-catenin/EMT signaling cascade in gastric cancer.
Huang J; He Y; Mcleod HL; Xie Y; Xiao D; Hu H; Chen P; Shen L; Zeng S; Yin X; Ge J; Li L; Tang L; Ma J; Chen Z
BMC Cancer; 2017 Dec; 17(1):886. PubMed ID: 29273006
[TBL] [Abstract][Full Text] [Related]
17. Acetyl-11-keto-β-boswellic acid (AKBA) inhibits human gastric carcinoma growth through modulation of the Wnt/β-catenin signaling pathway.
Zhang YS; Xie JZ; Zhong JL; Li YY; Wang RQ; Qin YZ; Lou HX; Gao ZH; Qu XJ
Biochim Biophys Acta; 2013 Jun; 1830(6):3604-15. PubMed ID: 23500016
[TBL] [Abstract][Full Text] [Related]
18. Abacavir induces the transcriptional activity of YY1 and other oncogenic transcription factors in gastric cancer cells.
Panneerpandian P; Devanandan HJ; Marimuthu A; Karthikeyan C; Ganesan K
Antiviral Res; 2020 Feb; 174():104695. PubMed ID: 31846633
[TBL] [Abstract][Full Text] [Related]
19. Antisense human telomerase reverse transcriptase could partially reverse malignant phenotypes of gastric carcinoma cell line in vitro.
Yang SM; Fang DC; Yang JL; Chen L; Luo YH; Liang GP
Eur J Cancer Prev; 2008 Jun; 17(3):209-17. PubMed ID: 18414191
[TBL] [Abstract][Full Text] [Related]
20. BTG1 expression correlates with pathogenesis, aggressive behaviors and prognosis of gastric cancer: a potential target for gene therapy.
Zheng HC; Li J; Shen DF; Yang XF; Zhao S; Wu YZ; Takano Y; Sun HZ; Su RJ; Luo JS; Gou WF
Oncotarget; 2015 Aug; 6(23):19685-705. PubMed ID: 26050197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
